NZ215020A - Controlled release formulations containing ergot alkaloids - Google Patents

Controlled release formulations containing ergot alkaloids

Info

Publication number
NZ215020A
NZ215020A NZ215020A NZ21502086A NZ215020A NZ 215020 A NZ215020 A NZ 215020A NZ 215020 A NZ215020 A NZ 215020A NZ 21502086 A NZ21502086 A NZ 21502086A NZ 215020 A NZ215020 A NZ 215020A
Authority
NZ
New Zealand
Prior art keywords
controlled release
release formulations
formulations containing
ergot alkaloids
containing ergot
Prior art date
Application number
NZ215020A
Other languages
English (en)
Inventor
O Zuger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ215020A publication Critical patent/NZ215020A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ215020A 1985-02-05 1986-02-03 Controlled release formulations containing ergot alkaloids NZ215020A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (1)

Publication Number Publication Date
NZ215020A true NZ215020A (en) 1989-07-27

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ215020A NZ215020A (en) 1985-02-05 1986-02-03 Controlled release formulations containing ergot alkaloids

Country Status (24)

Country Link
JP (1) JPS61183225A (es)
KR (1) KR920010388B1 (es)
AU (1) AU597570B2 (es)
BE (1) BE904152A (es)
CA (1) CA1263087A (es)
CH (1) CH667592A5 (es)
CY (1) CY1604A (es)
DE (1) DE3602577A1 (es)
DK (1) DK167138B1 (es)
ES (1) ES8800040A1 (es)
FR (1) FR2576787B1 (es)
GB (1) GB2170407B (es)
GR (1) GR860310B (es)
HK (1) HK57191A (es)
HU (1) HU195729B (es)
IE (1) IE59293B1 (es)
IT (1) IT1191255B (es)
LU (1) LU86289A1 (es)
NL (1) NL8600161A (es)
NZ (1) NZ215020A (es)
PH (1) PH23384A (es)
PT (1) PT81954B (es)
SE (1) SE8600496L (es)
SG (1) SG56191G (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
SI8710406B (sl) * 1987-03-11 1998-08-31 Lek Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
EP1235574B1 (en) * 1999-12-03 2005-02-02 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
EP1282412B1 (en) * 2000-05-12 2008-01-16 Meracol Corporation Limited Treating irritable bowel syndrome or disease
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
ES2298237T3 (es) * 2000-05-12 2008-05-16 Meracol Corporation Limited Cetil miristato y cetil palmitato para el tratamiento del eczema y/o de la soriasis.
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
IT8647620A0 (it) 1986-02-05
DK52086D0 (da) 1986-02-03
IE860291L (en) 1986-08-05
SG56191G (en) 1991-08-23
GB2170407A (en) 1986-08-06
KR920010388B1 (ko) 1992-11-27
PT81954B (pt) 1988-07-01
GB8602602D0 (en) 1986-03-12
PH23384A (en) 1989-07-26
IT1191255B (it) 1988-02-24
CA1263087A (en) 1989-11-21
LU86289A1 (fr) 1986-09-02
FR2576787B1 (fr) 1990-01-12
HK57191A (en) 1991-08-02
GB2170407B (en) 1988-10-26
FR2576787A1 (fr) 1986-08-08
DE3602577A1 (de) 1986-08-28
HUT41984A (en) 1987-06-29
NL8600161A (nl) 1986-09-01
AU597570B2 (en) 1990-06-07
CY1604A (en) 1992-04-03
ES8800040A1 (es) 1987-10-16
KR860006265A (ko) 1986-09-09
DK52086A (da) 1986-08-06
SE8600496L (sv) 1986-08-06
ES551635A0 (es) 1987-10-16
PT81954A (en) 1986-03-01
BE904152A (fr) 1986-08-04
IE59293B1 (en) 1994-02-09
AU5294286A (en) 1986-08-14
JPS61183225A (ja) 1986-08-15
CH667592A5 (de) 1988-10-31
SE8600496D0 (sv) 1986-02-04
GR860310B (en) 1986-05-27
DK167138B1 (da) 1993-09-06
HU195729B (en) 1988-07-28

Similar Documents

Publication Publication Date Title
GB2207353B (en) Controlled release formulation
IL80643A0 (en) Controlled release pharmaceutical compositions
EP0187703A3 (en) Sustained release preparation
EP0306236A3 (en) Controlled release formulations
NZ217387A (en) Controlled release tablets
NZ216966A (en) Controlled release device
ZA866052B (en) Prolonged release of growth promoting hormones
NZ214534A (en) Sustained release formulation containing theophylline
IL66113A0 (en) Pharmaceutical formulations containing ergot alkaloids
NZ215020A (en) Controlled release formulations containing ergot alkaloids
GB2125041B (en) Ergot alkaloids
PH21234A (en) Ergot alkaloids
GB2181431B (en) Catechol derivatives
GB2176984B (en) Soil plug release apparatus
EP0217735A3 (en) 2-substituted ergoline derivatives
NZ211247A (en) Controlled release formulation containing bromocriptine
GB8521221D0 (en) Controlled release formulations
GB2115811B (en) Ergot alkaloids
GB2092570B (en) Ergot alkaloids
GB2094798B (en) Ergot alkaloids
EG17797A (en) Controlled release formulation
ZA83955B (en) Ergot alkaloids
ZA86848B (en) Pharmaceutical 9,-10-dihydrogenated ergot alkaloid containing compositions
ZA878442B (en) Imidazopyridine compounds and processes for preparation thereof
IE852788L (en) Controlled release powder